Following quicker approval times for biopharmaceuticals, the Korean Ministry of Food and Drug Safety (MFDS) will review and plan to expedite registration for innovative medical devices. Various government departments and medical institutions will determine within 30 days if the device meets the criteria to be designated as an innovative medical device. If it does, review times will be reduced from 250 to 80 days. Medical devices utilizing AI and new digital technologies will be included in the innovative medical device category. Devices designated as innovative will also be reviewed by the Health Insurance and Assessment Service (HIRA) for reimbursement more quickly.
